Shatsky v. The Palestine Liberation Organization

District Court, S.D. New York·Decided December 6, 2021·No. 1:18-cv-12355·Unknown

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK

SHABTAI SCOTT SHATSKY, individually and as personal representative of the Estate of Keren Shatsky, et al. 18cv12355 (MKV) (DF) Plaintiffs, ORDER -against- THE PALESTINE LIBERATION ORGANIZATION, and THE PALESTINIAN AUTHORITY (a/k/a “The Palestinian Interim Self-Government Authority” and/or “The Palestinian National Authority”), Defendants. DEBRA FREEMAN, United States Magistrate Judge: In February 2021, the Honorable Mary Kay Vyskocil, U.S.D.J., granted the request by Plaintiffs in this case1 to conduct discovery on the question of whether the Court may exercise personal jurisdiction over defendants The Palestine Liberation Organization (“PLO”) and The Palestinian Authority (“PA”) (together, “Defendants”), under the Promoting Security and Justice for Victims of Terrorism Act of 2019 (the “PSJVTA”). (Dkt. 60.) Soon after, Plaintiffs sought to depose several of Defendants’ representatives, all of whom Plaintiffs claimed had knowledge of facts directly relevant to determining whether Defendants had engaged in conduct that, under the PSJVTA, would constitute consent to personal jurisdiction. In anticipation of those depositions, Judge Vyskocil issued an Order of Reference to this Court in June 2021, for the purpose of resolving any “objections to [the] scope of questioning during [the] depositions

1 This case arises out of a suicide bombing in the Israeli West Bank in 2002. Plaintiffs are the American victims of that bombing and their families. for jurisdictional discovery.” (Dkt. 93.) It is this Court’s understanding that Judge Vyskocil expected that, pursuant to that Order of Reference, this Court would resolve any discovery disputes arising out of, or connected to, Defendants’ invocation of “functional immunity”2 in relation to their representatives’ deposition testimony.3 On August 20, 2021, Defendants filed a motion to dismiss for lack of personal

jurisdiction (Dkt. 115), followed by a separate motion for summary judgment (Dkt. 118). Plaintiffs have opposed both motions and, in so doing, have submitted exhibits in support of their opposition, which include excerpts of Defendants’ representatives’ deposition testimony, as well as documents that were marked as exhibits during those same depositions. As immediately relevant here, Plaintiffs submitted the following materials as exhibits to an attorney declaration (Declaration of Oliver S. Haker, Esq. in Support of Plaintiffs’ Opposition to Defendants’ Motion to Dismiss for Lack of Personal Jurisdiction, dated Oct. 4, 2021 (“Haker Decl.”)), filed at Dkt. 130:

2 Under the Convention on the Privileges and Immunities of the United Nations (“U.N. Convention”), Feb. 13, 1946, 21 U.S.T. 1418, T I.A.S. 6900, acceded to by the United States in 1970, and Section 7(b) of the International Organizations Immunities Act (the “IOIA”), Title I, 59 Stat. 671 (1945), codified at 22 U.S.C. § 288d(b), United Nations officers and employees are entitled to “functional immunity,” meaning they are “immune from suit and legal process relating to acts performed by them in their official capacity and falling within their functions as . . . officers . . . or employees except insofar as such immunity may be waived” by the United Nations. IOIA, 22 U.S.C. § 288d(b) (emphasis added); see Van Aggelen v. United Nations, 311 Fed. App’x 407, 409 (Summary Order) (2d Cir. 2009) (although a United Nations employee “does not enjoy full diplomatic immunity,” he “is shielded by functional immunity” under the U.N. Convention for “all acts performed in his official capacity” (internal quotation marks, brackets, and ellipses omitted)). 3 With that understanding in mind, this Court held a telephone conference with the parties on July 6, 2021 (see Dkt. 96), at which time the scope of anticipated depositions was discussed. Then, as depositions were conducted in the following weeks, this Court made itself available to the parties, in the event they needed assistance in resolving functional-immunity-related objections made during the course of any of the depositions. No such issues, however, were brought to this Court’s attention during the depositions. (1) Haker Decl., Ex. 1 (Excerpts of the transcript of the deposition of Riyad Mansour, conducted on July 8, 2021 (“Mansour Deposition”));

(2) Haker Decl., Ex. 2 (Excerpts of the transcript of the deposition of Nadia Ghannam, conducted July 23, 2021 (“Ghannam Deposition”));

(3) Haker Decl., Ex. 264 (Excerpts of the transcript of the deposition of Feda Abdelhady Nasser, conducted July 22, 2021 (“Abdelhady-Nasser Deposition”)); and

(4) Haker Decl., Ex. 265 (Exhibit 3 to the Mansour Deposition, conducted on July 8, 2021, bearing production numbers Shatsky-JD00545 to Shatsky-JD00550 (“Mansour Deposition Exhibit 3”)). (See also Haker Decl. ¶¶ 2-3, 575-76.) Notably, for the three exhibits containing deposition testimony, Plaintiffs did not identify the specific pages of the transcript “excerpts” that they were submitting. Further, none of these four exhibits were filed on the Court’s electronic Docket, either in their entirety, or in redacted form, or even under seal with a “restricted view” designation, which would have at least provided the Court and case participants with electronic access to the documents. Rather, it appears that Plaintiffs took the position that, as Defendants had designated the exhibits as “Confidential” in their entirety under the existing Confidentiality Order in this case (Superseding Stipulation and Order Concerning Production of Confidential Documents and Information, entered Mar. 11, 2021 (Dkt. 64)), and as Plaintiffs wished to submit a large volume of such “Confidential” material to the Court in connection with their opposition to the motion to dismiss, it would be overly burdensome for Plaintiffs to file either redacted or unredacted versions on the Court’s Docket. Instead, Plaintiffs sought merely to provide hard copies of the exhibits (together with other material that was similarly designated as “Confidential”) to Judge Vyskocil’s Chambers (see Dkt. 128), and, in the filings that Plaintiffs then made electronically, they indicated that the exhibits, in their entirety, had been “redacted” from their submissions (see generally Dkt. 130 (exhibits)). Now before the Court are two letter motions, filed by non-parties, requesting that the above-mentioned exhibits (or portions thereof) be “unsealed” and that certain other discovery material also be made available to the public, as follows:

(1) First, interested party Arnold & Porter Kaye Scholer LLP (“Arnold & Porter”), the law firm representing the plaintiffs in a separate action titled Sokolow v. Palestine Liberation Organization, Case No. 04cv394 (GBD),4 has submitted multiple (duplicative) letters (see Dkts. 99, 100, 101), requesting that the following be made available to the public:

(a) the Abelhady-Nasser Deposition, at pp. 1-4, 58-128, 189-191;5

(b) the Ghannam Deposition, at pp. 1-4, 39-41, 144-201;

(c) the Mansour Deposition, at pp. 1-4, 44-77, 86-120, 177-82;

(d) Abdelhady-Nasser Deposition Exhibits 4-6; and

(e) Mansour Deposition Exhibits 3-4.

(See Dkt. 101, at n.2.)

4 Sokolow is another case in this District in which the defendants are litigating the existence of personal jurisdiction under the PSJVTA. See Case No. 04cv394 (GBD). On July 2, 2021, Judge Vyskocil granted Arnold & Porter’s application to modify the existing Confidentiality Order in this case to allow Arnold & Porter to access and use, in Sokolow, the confidential jurisdictional discovery materials produced herein. (Dkt.

Free access — add to your briefcase to read the full text and ask questions with AI

Shatsky v. The Palestine Liberation Organization, (S.D.N.Y. 2021).

Shatsky v. The Palestine Liberation Organization (Shatsky v. The Palestine Liberation Organization) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Lugosch v. Pyramid Co. of Onondaga
435 F.3d 110 (Second Circuit, 2006)